Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:MYOS

MYOS RENS Technology (MYOS) Stock Price, News & Analysis

About MYOS RENS Technology Stock (NASDAQ:MYOS)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$1.01
$11.40
52-Week Range
N/A
Volume
N/A
Average Volume
1.68 million shs
Market Capitalization
$16.70 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive MYOS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for MYOS RENS Technology and its competitors with MarketBeat's FREE daily newsletter.

MYOS Stock News Headlines

Trump’s treachery
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.
Bio-active Peptides Market Size Dynamics 2023-2029
See More Headlines

MYOS Stock Analysis - Frequently Asked Questions

MYOS RENS Technology Inc. (NASDAQ:MYOS) issued its quarterly earnings results on Tuesday, August, 6th. The company reported ($0.13) earnings per share for the quarter, missing the consensus estimate of ($0.12) by $0.01. The company had revenue of $0.15 million for the quarter, compared to analysts' expectations of $0.14 million. MYOS RENS Technology had a negative trailing twelve-month return on equity of 166.68% and a negative net margin of 277.82%.

Based on aggregate information from My MarketBeat watchlists, some other companies that MYOS RENS Technology investors own include Chesapeake Energy (CHKAQ), Catalyst Pharmaceuticals (CPRX), Ampio Pharmaceuticals (AMPE), Biocept (BIOC), T2 Biosystems (TTOO), AbbVie (ABBV) and Global Blood Therapeutics (GBT).

Company Calendar

Last Earnings
8/06/2019
Today
7/11/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:MYOS
CIK
1402479
Fax
N/A
Employees
15
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$4.26 million
Net Margins
-277.82%
Pretax Margin
N/A
Return on Equity
-166.68%
Return on Assets
-104.95%

Debt

Debt-to-Equity Ratio
0.11
Current Ratio
3.78
Quick Ratio
1.94

Sales & Book Value

Annual Sales
$1.03 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.13 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
12,192,000
Free Float
N/A
Market Cap
$16.70 million
Optionable
Not Optionable
Beta
1.08
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (NASDAQ:MYOS) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners